Kidney Cancer News & Features
Use of either Nexavar (sorafenib) or Sutent (sunitinib) provide no benefit to patients with locally advanced renal cell carcinoma.
In situations where small renal tumors confined to the kidneys, active monitoring, as opposed to immediate surgery, is associated with low rates of tumor growth or mortality.
In patients likely to have surgery, close monitoring of small renal tumors is associated with low rates of cancer growth or mortality.
A test that has the potential to improve treatment of patients with clear cell renal cell carcinoma (ccRCC).
Organ preservation in kidney cancer more likely at facilities that are early adopters of robotic surgery
Patients with operable kidney cancers were more likely to have a partial nephrectomy, which is the recommended treatment for localized tumors, when treated in hospitals that were early adopters of robotic surgery, according to a new study.
Kidney Cancer Videos
Kidney Cancer Clinical Trials
- Study may support active surveillance for favorable intermediate-risk prostate cancer
- New mechanism of acquired resistance to breast cancer drugs discovered
- Two major studies strengthen case for prostate cancer drug before chemotherapy
- Finding a qualified acupuncture practitioner
- New opportunity to treat drug-resistant leukemia discovered
- High-cost blood cancer drugs deliver high value
- Statins increase risk of diabetes in Caucasian men
- Sun damage predisposes pediatric patients to melanoma
- Risk of reproductive cancers increased in daughters of women who smoked during pregnancy
- Older white males with advanced bladder cancer more likely to commit suicide
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|